pentakis((4-methylpyrazol-1-yl)-[4-(naphthalen-2-ylmethyl)piperazin-1-yl]methanone);bis((4-methylpyrazol-1-yl)-[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]methanone);(4-methylpyrazol-1-yl)-[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]methanone;[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone;[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone

C210H230N40O15 — CID 157283758

IUPACpentakis((4-methylpyrazol-1-yl)-[4-(naphthalen-2-ylmethyl)piperazin-1-yl]methanone);bis((4-methylpyrazol-1-yl)-[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]methanone);(4-methylpyrazol-1-yl)-[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]methanone;[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone;[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone
SMILESCc1cnn(C(=O)N2CCN(Cc3ccc(OCc4ccccc4)cc3)CC2)c1.Cc1cnn(C(=O)N2CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)c1.Cc1cnn(C(=O)N2CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)c1.Cc1cnn(C(=O)N2CCN(Cc3ccc4ccccc4c3)CC2)c1.Cc1cnn(C(=O)N2CCN(Cc3ccc4ccccc4c3)CC2)c1.Cc1cnn(C(=O)N2CCN(Cc3ccc4ccccc4c3)CC2)c1.Cc1cnn(C(=O)N2CCN(Cc3ccc4ccccc4c3)CC2)c1.Cc1cnn(C(=O)N2CCN(Cc3ccc4ccccc4c3)CC2)c1.O=C(N1CCN(Cc2ccc(OCc3ccccc3)cc2)CC1)n1cccn1.O=C(N1CCN(Cc2ccc(Oc3ccccc3)cc2)CC1)n1cccn1
InChIInChI=1S/C23H26N4O2.3C22H24N4O2.C21H22N4O2.5C20H22N4O/c1-19-15-24-27(16-19)23(28)26-13-11-25(12-14-26)17-20-7-9-22(10-8-20)29-18-21-5-3-2-4-6-21;2*1-18-15-23-26(16-18)22(27)25-13-11-24(12-14-25)17-19-7-9-21(10-8-19)28-20-5-3-2-4-6-20;27-22(26-12-4-11-23-26)25-15-13-24(14-16-25)17-19-7-9-21(10-8-19)28-18-20-5-2-1-3-6-20;26-21(25-12-4-11-22-25)24-15-13-23(14-16-24)17-18-7-9-20(10-8-18)27-19-5-2-1-3-6-19;5*1-16-13-21-24(14-16)20(25)23-10-8-22(9-11-23)15-17-6-7-18-4-2-3-5-19(18)12-17/h2-10,15-16H,11-14,17-18H2,1H3;2*2-10,15-16H,11-14,17H2,1H3;1-12H,13-18H2;1-12H,13-17H2;5*2-7,12-14H,8-11,15H2,1H3
InChIKeyAZZCRUUWFVOKOC-UHFFFAOYSA-N
MW3554.41 g/mol
LogP33.46
Rot. Bonds32

About pentakis((4-methylpyrazol-1-yl)-[4-(naphthalen-2-ylmethyl)piperazin-1-yl]methanone);bis((4-methylpyrazol-1-yl)-[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]methanone);(4-methylpyrazol-1-yl)-[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]methanone;[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone;[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone

pentakis((4-methylpyrazol-1-yl)-[4-(naphthalen-2-ylmethyl)piperazin-1-yl]methanone);bis((4-methylpyrazol-1-yl)-[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]methanone);(4-methylpyrazol-1-yl)-[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]methanone;[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone;[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone (PubChem CID 157283758) has the molecular formula C210H230N40O15 and a molecular weight of 3554.41 g/mol. Its IUPAC name is pentakis((4-methylpyrazol-1-yl)-[4-(naphthalen-2-ylmethyl)piperazin-1-yl]methanone);bis((4-methylpyrazol-1-yl)-[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]methanone);(4-methylpyrazol-1-yl)-[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]methanone;[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone;[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone.

Molecular Properties

Compound Namepentakis((4-methylpyrazol-1-yl)-[4-(naphthalen-2-ylmethyl)piperazin-1-yl]methanone);bis((4-methylpyrazol-1-yl)-[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]methanone);(4-methylpyrazol-1-yl)-[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]methanone;[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone;[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone
PubChem CID157283758
Molecular FormulaC210H230N40O15
Molecular Weight3554.41 g/mol
Exact Mass3551.85
IUPAC Namepentakis((4-methylpyrazol-1-yl)-[4-(naphthalen-2-ylmethyl)piperazin-1-yl]methanone);bis((4-methylpyrazol-1-yl)-[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]methanone);(4-methylpyrazol-1-yl)-[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]methanone;[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone;[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone
SMILESCc1cnn(C(=O)N2CCN(Cc3ccc(OCc4ccccc4)cc3)CC2)c1.Cc1cnn(C(=O)N2CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)c1.Cc1cnn(C(=O)N2CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)c1.Cc1cnn(C(=O)N2CCN(Cc3ccc4ccccc4c3)CC2)c1.Cc1cnn(C(=O)N2CCN(Cc3ccc4ccccc4c3)CC2)c1.Cc1cnn(C(=O)N2CCN(Cc3ccc4ccccc4c3)CC2)c1.Cc1cnn(C(=O)N2CCN(Cc3ccc4ccccc4c3)CC2)c1.Cc1cnn(C(=O)N2CCN(Cc3ccc4ccccc4c3)CC2)c1.O=C(N1CCN(Cc2ccc(OCc3ccccc3)cc2)CC1)n1cccn1.O=C(N1CCN(Cc2ccc(Oc3ccccc3)cc2)CC1)n1cccn1
InChIInChI=1S/C23H26N4O2.3C22H24N4O2.C21H22N4O2.5C20H22N4O/c1-19-15-24-27(16-19)23(28)26-13-11-25(12-14-26)17-20-7-9-22(10-8-20)29-18-21-5-3-2-4-6-21;2*1-18-15-23-26(16-18)22(27)25-13-11-24(12-14-25)17-19-7-9-21(10-8-19)28-20-5-3-2-4-6-20;27-22(26-12-4-11-23-26)25-15-13-24(14-16-25)17-19-7-9-21(10-8-19)28-18-20-5-2-1-3-6-20;26-21(25-12-4-11-22-25)24-15-13-23(14-16-24)17-18-7-9-20(10-8-18)27-19-5-2-1-3-6-19;5*1-16-13-21-24(14-16)20(25)23-10-8-22(9-11-23)15-17-6-7-18-4-2-3-5-19(18)12-17/h2-10,15-16H,11-14,17-18H2,1H3;2*2-10,15-16H,11-14,17H2,1H3;1-12H,13-18H2;1-12H,13-17H2;5*2-7,12-14H,8-11,15H2,1H3
InChIKeyAZZCRUUWFVOKOC-UHFFFAOYSA-N
XLogP33.46
TPSA459.85 Ų
H-Bond Donors
H-Bond Acceptors45
Rotatable Bonds32
Heavy Atoms265
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003554.41
LogP ≤ 533.46
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1045

Analyze pentakis((4-methylpyrazol-1-yl)-[4-(naphthalen-2-ylmethyl)piperazin-1-yl]methanone);bis((4-methylpyrazol-1-yl)-[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]methanone);(4-methylpyrazol-1-yl)-[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]methanone;[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone;[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of pentakis((4-methylpyrazol-1-yl)-[4-(naphthalen-2-ylmethyl)piperazin-1-yl]methanone);bis((4-methylpyrazol-1-yl)-[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]methanone);(4-methylpyrazol-1-yl)-[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]methanone;[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone;[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone?
The IUPAC name of pentakis((4-methylpyrazol-1-yl)-[4-(naphthalen-2-ylmethyl)piperazin-1-yl]methanone);bis((4-methylpyrazol-1-yl)-[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]methanone);(4-methylpyrazol-1-yl)-[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]methanone;[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone;[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone (CID 157283758) is pentakis((4-methylpyrazol-1-yl)-[4-(naphthalen-2-ylmethyl)piperazin-1-yl]methanone);bis((4-methylpyrazol-1-yl)-[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]methanone);(4-methylpyrazol-1-yl)-[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]methanone;[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone;[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone.
What is the SMILES notation for pentakis((4-methylpyrazol-1-yl)-[4-(naphthalen-2-ylmethyl)piperazin-1-yl]methanone);bis((4-methylpyrazol-1-yl)-[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]methanone);(4-methylpyrazol-1-yl)-[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]methanone;[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone;[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone?
The canonical SMILES for pentakis((4-methylpyrazol-1-yl)-[4-(naphthalen-2-ylmethyl)piperazin-1-yl]methanone);bis((4-methylpyrazol-1-yl)-[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]methanone);(4-methylpyrazol-1-yl)-[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]methanone;[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone;[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone is Cc1cnn(C(=O)N2CCN(Cc3ccc(OCc4ccccc4)cc3)CC2)c1.Cc1cnn(C(=O)N2CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)c1.Cc1cnn(C(=O)N2CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)c1.Cc1cnn(C(=O)N2CCN(Cc3ccc4ccccc4c3)CC2)c1.Cc1cnn(C(=O)N2CCN(Cc3ccc4ccccc4c3)CC2)c1.Cc1cnn(C(=O)N2CCN(Cc3ccc4ccccc4c3)CC2)c1.Cc1cnn(C(=O)N2CCN(Cc3ccc4ccccc4c3)CC2)c1.Cc1cnn(C(=O)N2CCN(Cc3ccc4ccccc4c3)CC2)c1.O=C(N1CCN(Cc2ccc(OCc3ccccc3)cc2)CC1)n1cccn1.O=C(N1CCN(Cc2ccc(Oc3ccccc3)cc2)CC1)n1cccn1.
What is the InChIKey of pentakis((4-methylpyrazol-1-yl)-[4-(naphthalen-2-ylmethyl)piperazin-1-yl]methanone);bis((4-methylpyrazol-1-yl)-[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]methanone);(4-methylpyrazol-1-yl)-[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]methanone;[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone;[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone?
The InChIKey is AZZCRUUWFVOKOC-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H26N4O2.3C22H24N4O2.C21H22N4O2.5C20H22N4O/c1-19-15-24-27(16-19)23(28)26-13-11-25(12-14-26)17-20-7-9-22(10-8-20)29-18-21-5-3-2-4-6-21;2*1-18-15-23-26(16-18)22(27)25-13-11-24(12-14-25)17-19-7-9-21(10-8-19)28-20-5-3-2-4-6-20;27-22(26-12-4-11-23-26)25-15-13-24(14-16-25)17-19-7-9-21(10-8-19)28-18-20-5-2-1-3-6-20;26-21(25-12-4-11-22-25)24-15-13-23(14-16-24)17-18-7-9-20(10-8-18)27-19-5-2-1-3-6-19;5*1-16-13-21-24(14-16)20(25)23-10-8-22(9-11-23)15-17-6-7-18-4-2-3-5-19(18)12-17/h2-10,15-16H,11-14,17-18H2,1H3;2*2-10,15-16H,11-14,17H2,1H3;1-12H,13-18H2;1-12H,13-17H2;5*2-7,12-14H,8-11,15H2,1H3.
What are the key properties of pentakis((4-methylpyrazol-1-yl)-[4-(naphthalen-2-ylmethyl)piperazin-1-yl]methanone);bis((4-methylpyrazol-1-yl)-[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]methanone);(4-methylpyrazol-1-yl)-[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]methanone;[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone;[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone?
pentakis((4-methylpyrazol-1-yl)-[4-(naphthalen-2-ylmethyl)piperazin-1-yl]methanone);bis((4-methylpyrazol-1-yl)-[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]methanone);(4-methylpyrazol-1-yl)-[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]methanone;[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone;[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone has a molecular weight of 3554.41 g/mol, XLogP of 33.46, 32 rotatable bonds, 0 hydrogen bond donors, and 45 hydrogen bond acceptors.
Where does this data come from?
All data for pentakis((4-methylpyrazol-1-yl)-[4-(naphthalen-2-ylmethyl)piperazin-1-yl]methanone);bis((4-methylpyrazol-1-yl)-[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]methanone);(4-methylpyrazol-1-yl)-[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]methanone;[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone;[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]-pyrazol-1-ylmethanone is sourced from PubChem (CID 157283758), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).